Geron reported $324K in Ordinary Share Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Amgen AMGN:US $ 31247M 849M
Bio Techne TECH:US $ 0.39M 0M
Cti Biopharma CTIC:US $ 0.1M 0M
Cytokinetics CYTK:US $ 0.08M 0M
Esperion Therapeutics ESPR:US $ 61K 0
Exelixis EXEL:US $ 0.32M 0M
Genmab GEN:DC DK 66M 0M
Geron GERN:US $ 0.32M 0M
Gilead Sciences GILD:US $ 1M 0M
Macrogenics MGNX:US $ 0.61M 0M
Novartis NOVN:VX SF 901M 0M
Novavax NVAX:US $ 0.79M 0.02M
Pain Therapeutics PTIE:US $ 0.04M 0M
Seattle Genetics SGEN:US $ 0.18M 0M
YTE INCY:US $ 0.22M 0M